1. Strategies for iron supplementation: Oral versus intravenous
Iain C. Macdougall 
Kidney International 
Volume 55, Pages S61-S66 (March 1999)
DOI: /j Suppl x
Copyright © 1999 International Society of Nephrology Terms and Conditions

2. Figure 1
Hemoglobin response (mean ±SD) in three groups of erythropoietin-treated patients with different regimens of iron supplementation. Symbols are: (•) i.v. iron; (○) oral iron; (▪) no iron; *P < 0.05; **P < vs. i.v. iron-treated group. Taken from Macdougall et al22; used with permission.
Kidney International  , S61-S66DOI: ( /j Suppl x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

3. Figure 2
Mean hematocrit in two groups of patients receiving erythropoietin. Squares indicate the intravenous iron group; diamonds indicate the oral iron group. *P < Taken from Fishbane et al20; used with permission.
Kidney International  , S61-S66DOI: ( /j Suppl x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

4. Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999
Kidney International  , S61-S66DOI: ( /j Suppl x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

5. Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999
Kidney International  , S61-S66DOI: ( /j Suppl x)
Copyright © 1999 International Society of Nephrology Terms and Conditions

6. Kidney International 1999 55, S61-S66DOI: (10. 1046/j. 1523-1755. 1999
Kidney International  , S61-S66DOI: ( /j Suppl x)
Copyright © 1999 International Society of Nephrology Terms and Conditions